Allergy Therapeutics plc (AIM:AGY)
11.50
-0.89 (-7.72%)
Mar 9, 2026, 4:35 PM GMT
Allergy Therapeutics Ratios and Metrics
Market cap in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 728 | 379 | 250 | 7 | 134 | 160 | Upgrade
|
| Market Cap Growth | 128.04% | 51.72% | 3402.67% | -94.66% | -16.71% | 80.14% | Upgrade
|
| Enterprise Value | 776 | 402 | 246 | 2 | 102 | 124 | Upgrade
|
| Last Close Price | 0.12 | 0.08 | 0.05 | 0.00 | 0.10 | 0.12 | Upgrade
|
| PE Ratio | - | - | - | - | - | 55.59 | Upgrade
|
| PS Ratio | 13.23 | 6.88 | 4.53 | 0.12 | 1.84 | 1.90 | Upgrade
|
| PB Ratio | -25.83 | -13.44 | 33.95 | 3.45 | 3.54 | 3.31 | Upgrade
|
| P/TBV Ratio | - | - | 93.58 | - | 4.08 | 3.67 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 26.62 | Upgrade
|
| P/OCF Ratio | - | - | - | - | - | 18.68 | Upgrade
|
| PEG Ratio | - | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 | Upgrade
|
| EV/Sales Ratio | 14.09 | 7.30 | 4.46 | 0.03 | 1.40 | 1.47 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | - | 20.31 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | - | 31.62 | Upgrade
|
| EV/FCF Ratio | -24.72 | - | - | - | - | 20.60 | Upgrade
|
| Debt / Equity Ratio | -2.13 | -2.13 | 4.21 | 17.42 | 0.28 | 0.23 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | - | 1.44 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 1.85 | Upgrade
|
| Net Debt / Equity Ratio | -1.68 | -1.68 | 2.46 | 10.23 | -0.26 | -0.60 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.81 | -1.81 | -0.56 | -0.64 | 0.98 | -4.76 | Upgrade
|
| Net Debt / FCF Ratio | -1.51 | -1.51 | -0.51 | -0.63 | 0.59 | -4.83 | Upgrade
|
| Asset Turnover | 0.82 | 0.82 | 0.83 | 0.85 | 0.90 | 0.97 | Upgrade
|
| Inventory Turnover | 1.93 | 1.93 | 2.09 | 2.29 | 2.09 | 2.11 | Upgrade
|
| Quick Ratio | 0.69 | 0.69 | 1.02 | 1.07 | 1.46 | 2.46 | Upgrade
|
| Current Ratio | 1.27 | 1.27 | 1.78 | 1.81 | 2.35 | 3.17 | Upgrade
|
| Return on Equity (ROE) | - | - | -819.81% | -216.27% | -31.93% | 6.25% | Upgrade
|
| Return on Assets (ROA) | -26.58% | -26.58% | -32.23% | -31.48% | -9.60% | 2.81% | Upgrade
|
| Return on Invested Capital (ROIC) | -149.09% | -127.92% | -141.18% | -138.02% | -52.41% | 16.12% | Upgrade
|
| Return on Capital Employed (ROCE) | -70.60% | -70.60% | -72.10% | -73.00% | -22.50% | 5.60% | Upgrade
|
| Earnings Yield | -5.51% | -10.59% | -15.46% | -604.03% | -10.31% | 1.80% | Upgrade
|
| FCF Yield | -4.31% | -8.28% | -14.23% | -470.51% | -12.76% | 3.76% | Upgrade
|
| Buyback Yield / Dilution | -27.33% | -27.33% | -458.41% | -4.26% | 4.98% | -0.47% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.